Mylan Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mylan Pharmaceuticals Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11511
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mylan Pharmaceuticals Pvt Ltd (Mylan), a subsidiary of Mylan NV, is a pharmaceutical company that manufactures generic, speciality and active pharmaceutical ingredients (API). The company provides products such as critical care products, hepato care products, HIV care products, onco care products and women care products, among others. Its products include tablets, capsules, oral solid doses (OSD), injectables, antifungal and antibacterial therapies, injectable antibiotics and antiretrovirals, among others. Mylan owns Active Pharmaceutical Ingredients (API) manufacturing facilities, research and development centers in Telangana, Tamil Nadu, Maharashtra and Andhra Pradesh. The company has operations across Europe, the US, Asia, and Africa. Mylan is headquartered in Bangalore, Karnataka, India.

Mylan Pharmaceuticals Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mylan Pharma Enters into Distribution Agreement with Gilead Sciences 10
Mylan Pharma Enters Into Distribution Agreement With Gilead Sciences 11
Licensing Agreements 12
Mylan Pharma Enters into Licensing Agreement with Otsuka Novel Products for Delamanid 12
Mylan Pharmaceuticals Pvt Ltd – Key Competitors 13
Mylan Pharmaceuticals Pvt Ltd – Key Employees 14
Mylan Pharmaceuticals Pvt Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mylan Pharmaceuticals Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mylan Pharma Enters into Distribution Agreement with Gilead Sciences 10
Mylan Pharma Enters Into Distribution Agreement With Gilead Sciences 11
Mylan Pharma Enters into Licensing Agreement with Otsuka Novel Products for Delamanid 12
Mylan Pharmaceuticals Pvt Ltd, Key Competitors 13
Mylan Pharmaceuticals Pvt Ltd, Key Employees 14
Mylan Pharmaceuticals Pvt Ltd, Other Locations 15

List of Figures
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mylan Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mylan Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Y.S.P. Southeast Asia Holding Berhad (YSPSAH):企業の財務・戦略的SWOT分析
    Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Hargreaves Lansdown PLC:企業の戦略・SWOT・財務情報
    Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GarrettCom, Inc.:企業の戦略的SWOT分析
    GarrettCom, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ALS Ltd (ALQ):石油・ガス:M&Aディール及び事業提携情報
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides offers chemical and laboratory services, technical testing and inspection servic …
  • Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析
    Meiji Holdings Co Ltd (2269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Petroleo Brasileiro SA (PETR4):企業の財務・戦略的SWOT分析
    Petroleo Brasileiro SA (PETR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Anagin Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagin Inc (Anagin) formerly Anagin LLC, is a biotechnology company which develops novel targeted therapies for the treatment of neuropsychiatric diseases. The company is focused on the development of first-in-class small molecule modulators of neurotransmitter signaling complexes that reduc …
  • Cameco Corporation:企業の戦略・SWOT・財務分析
    Cameco Corporation - Strategy, SWOT and Corporate Finance Report Summary Cameco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kuwait Petroleum International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Petroleum International Ltd (KPI), a subsidiary of Kuwait Petroleum Corporation, is a downstream energy company. It carries out refining of crude oil, production and marketing of refined petroleum products. The company operates refinery in Milazzo, Italy, and has retail service statio …
  • Suzuki Motor Corporation (7269):企業の財務・戦略的SWOT分析
    Suzuki Motor Corporation (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Grupa Lotos SA (LTS):企業の財務・戦略的SWOT分析
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Scomi Group Bhd (SCOMI):企業の財務・戦略的SWOT分析
    Scomi Group Bhd (SCOMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Manchester United Plc:企業の戦略・SWOT・財務情報
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sleep Number Corp (SNBR):企業の財務・戦略的SWOT分析
    Sleep Number Corp (SNBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • VolitionRX Ltd (VNRX):医療機器:M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Alibaba Pictures Group Limited:企業のM&A・事業提携・投資動向
    Alibaba Pictures Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Pictures Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Biocept Inc (BIOC):医療機器:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆